Sofosbuvir plus Daclatasvir without Ribavirin for the Treatment of Chronic Hepatitis C in Patients with Decompensated Liver Disease: Response of sofosbuvir plus daclatasvir in decompensated cirrhosis. (2020). Journal of Fatima Jinnah Medical University, 14(1), 41-44. https://doi.org/10.37018/WOXS1774